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fest  physiological abnormalities that lead to breathlessness and 
 reduction in exercise tolerance, while moderate and severe COPD 
may remarkably affect the quality of life and mortality.
There are many treatments for COPD, such as inhalational 
corticosteroid (ICS) and anticholinergics, salmeterol–fluticasone 
combination (SFC) or tiotropium, and the prescription of antibi-
otics. However, until now none of them was proved to be an ideal 
treatment for COPD. ICS could increase the incidence of pneumo-
nia (Drummond et al., 2008). Anticholinergics treatment showed a 
higher risk of cardiovascular morbidity and mortality (Singh et al., 
2008). In another study, tiotropium was showed unable to reduce 
the decline of FEV
1
 (Tashkin et al., 2008). Regarding the fact that 
COPD morbidity and mortality has been increasing in recent years, 
it would be greatly valuable to find out an effective therapy to COPD.
Oxidative stress is widely proposed as a pathogenic mechanism 
for COPD (Van der Vliet, 1999; Pinamonti et al., 1996; Repine et al., 
1997). Many researchers found markers of oxidative stress, such as 
H
2
O
2
 and NO, in the epithelial lining fluid, breath, and urine of COPD 
patients (Dekhuijzen et al., 1996; Maziak et al., 1998; Praticò et al., 
1998; Montuschi et al., 2000). Oxidant peroxynitrite, generated by the 
reaction of NO with superoxide anion, is reported to be highly corre-
lated with COPD (Kanazawa et al., 2003). Hydroxyl radical, produced 
by superoxide anion and H
2
O
2
 respectively through the Haber–Weiss 
reaction and Fenton reaction, is also a strong toxic oxidant (Halliwell 
and Gutteridge, 1986, 1992). Ichinose found abundant nitrotyrosine 
positive staining cells and iNOS positive cells in induced sputum of 
COPD patients, indicating that oxidative stress caused by reactive 
nitrogen species may be exaggerated in the airways in COPD patients 
and overproduction of reactive nitrogen species may contribute to 
pathogenesis of COPD (Ichinose et al., 2000). Accumulating evidences 
support that ROS is important in the incidence and exacerbation of 
COPD. First, oxidative stress, such as H
2
O
2
 and isoprostane F2a-III 
formed by free radical peroxidation of arachidonic acid, may induce 
IntroductIon
Hydrogen (H
2
), a colorless, tasteless, odorless, non-irritating, and 
highly flammable diatomic gas, was generally regarded as physi-
ologic inert gas in hyperbaric medicine. In 1975 and 2001, Dole 
et al. (1975) and Gharib et al. (2001) separately reported that H
2
 
under a high pressure might be a therapeutic gas for cancer and 
parasite-induced liver inflammation by eliminating toxic ROS. In 
2007, Ohsawa et al. (2007) found that 2% H
2
 inhalation exhib-
ited antioxidant and anti-apoptotic activities by selectively reduc-
ing cytotoxic oxygen radicals. The importance of H
2
 immediately 
drew widespread concerns and it is proved to be effective for many 
ROS-related diseases, such as hepatic and cardiac hypoxia–ischemia 
injury, inflammation injury caused by small intestine transplanta-
tion and neonatal hypoxia–ischemia injury (Fukuda et al., 2007; 
Buchholz et al., 2008; Cai et al., 2008; Hayashida et al., 2008). Besides, 
other ways to administrate H
2
, such as drinking H
2
-saturated water, 
intraperitoneal and intravenous injection of H
2
-saturated saline, 
were also effective to many disorders, such as cerebral hypoxia–
ischemia injury, human type II diabetes, nephrotoxicity induced by 
cisplatin, Parkinson’s disease and atherosclerosis in apolipoprotein 
(Cai et al., 2009; Chen et al., 2009; Mao et al., 2009; Sun et al., 2009; 
Zheng et al., 2009; Oharazawa et al., 2010). All these evidences show 
that molecule H
2
 is effective to diseases related to oxidative stress, 
which may include chronic obstructive pulmonary disease (COPD).
chronIc obstructIve pulmonary dIsease
Chronic obstructive pulmonary disease is a complex multifactorial 
disease mainly composed of chronic bronchitis and pulmonary 
emphysema, which is characterized by not fully reversible airflow 
limitation. The major feature of COPD is generally accepted as 
abnormal response to injury, chronic inflammation, excessive 
activation of macrophages, neutrophils, T lymphocytes, and 
 fibroblasts in the lung. People even with mild COPD often mani-
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nucleus. Second, as H
2
 selectively reacts with OH and ONOO− ,  
other important ROS (e.g., H
2
O
2
 and O2
−) involved in cell signaling 
are not decreased, so the metabolic oxidation–reduction reactions 
are not disturbed. Third, the tissue compatibility of H
2
 is stronger 
than many other oxidant scavengers. Especially, in lung the appli-
cation of H
2
 has some unique benefits. People have inhaled H
2
 for 
hundreds of years in diving and it is already proved to be very safe 
for inhalation. Moreover, inhaled H
2
 can easily reach the lung to 
play a therapeutic role. In addition, because of the special anatomi-
cal structure of lung, H
2
 can reach lung cells easily and quickly; 
Furthermore, if H
2
 inhalation is applied as a treatment, H
2
 will act 
on lung directly, leading to a better therapeutic effect. In conclu-
sion, as COPD has shown an increase in mortality in recent years, 
we hope H
2
 will successfully control the tread due to its potential 
protective effect.
reversible airway narrowing by constricting airway smooth muscle 
(Kawikova et al., 1996). Second, oxidants can promote inflammation 
by activating NF-kB and other pathways. Finally, oxidative stress can 
lead to a proteinase–antiproteinase imbalance (Park et al., 2009).
hypothesIs
Our hypothesis is that H
2
 may be a unique, effective, and specific 
treatment for COPD. Given the fact that H
2
 can eliminate ROS such 
as OH and ONOO−  and ROS is an important factor in the patho-
genic process in COPD, we hypothesize that H
2
 may be potentially 
effective for COPD by preventing its occurrence, exacerbation, and 
slowing its process.
Compared to other oxidant scavengers, H
2
 has its special advan-
tages. First, because of its small molecular weight, H
2
 can easily pen-
etrate bio-membranes and diffuse into cytosol, mitochondria, and 
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